NASDAQ · Biotechnology

Q32 Bio Inc. (QTTB) Stock

$8.34 +3.09% NASDAQ: QTTB Healthcare

Valuation

MetricValue
Price$8.34
Market Cap$248.23M
P/E Ratio2.95
P/B Ratio1.10
P/S Ratio4.56
EPS (TTM)$2.42
52-Week High$23.57
52-Week Low$1.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE76.88%
ROA29.16%
ROCE19.43%
Gross Margin31.48%
Operating Margin31.48%
Net Margin62.87%
Debt/Equity0.05
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$7.0M$-7.0M$0$54.0M
Operating Profit$-37.0M$-39.0M$-48.0M$-66.0M$17.0M
Net Profit$-38.0M$-43.0M$-54.0M$-48.0M$30.0M
EPS$-3.15$-3.59$-4.51$-6.58$2.42
Op Margin—-589.8%725.5%—31.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$212.0M$230.0M$47.0M$92.0M$62.0M
Total Liabilities$42.0M$52.0M$230.0M$87.0M$20.0M
Cash$108.0M$34.0M$26.0M$78.0M$48.0M
Borrowings$24.0M$30.0M$51.0M$19.0M$15.0M

Latest News

Wall Street Analysts See an 80.12% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? Zacks · Jul 15, 2026 Q32 Bio Prices $200 Million Offering of Stock, Pre-funded Warrants MT Newswires · Jul 15, 2026 Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PR Newswire · Jul 15, 2026 Q32 Bio stock surges 83% on positive alopecia drug trial data Quartz · Jul 14, 2026 Q32 Bio (QTTB) After Positive Trial Data Is It A Buy Or Already Fairly Valued Simply Wall St. · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-110.0M$-11.0M$-19.0M$-68.0M$-34.0M
Investing Cash Flow$-53.0M$-5.0M$0$20.0M$7.0M
Financing Cash Flow$0$0$0$46.0M$0
Net Cash Flow$-109.0M$17.0M$-8.0M$47.0M$-30.0M
Free Cash Flow$-112.0M$-13.0M$-19.0M$-68.0M$-34.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA4.16
FCF Yield-8.09%
Quick Ratio20.30
Interest Coverage16.51
Return 1Y654.81%
Return 3Y-8.19%
Return 5Y-86.41%

Ownership

Insiders Held4.24%
Institutions Held130.63%
Institutions Float Held136.43%
Institutional HolderSharesReport Date
Orbimed Advisors LLC.2,252,9872026-03-31
Atlas Venture Life Science Advisors, LLC 2,092,1062026-03-31
Opaleye Management Inc.1,256,2282026-03-31
Carlyle Group Inc.1,102,7412026-03-31
Arch Venture Management, Llc320,4822026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTXAN2 Therapeutics, Inc. $4.40 -5.98% -5.24 $158.47M 0.00%
BOLDBoundless Bio, Inc. $2.53 -1.94% -0.92 $56.86M 0.00%
GBIOGeneration Bio Co. $5.34 +0.00% -0.87 $35.98M 0.00%
INTSIntensity Therapeutics, Inc. $3.63 -1.36% -0.71 $9.81M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About Q32 Bio Inc.

Q32 Bio Inc. is led by CEO Jodie Pope Morrison, employs 28 people, headquartered in US, publicly traded since 2018.

Q32 Bio Inc. (QTTB) stock trades at $8.34 with a market capitalization of $248.23M. The stock is valued at a price-to-earnings (P/E) ratio of 2.95, price-to-book of 1.10, price-to-sales of 4.56. Over the past 52 weeks the stock has ranged between $1.91 and $23.57, and currently trades 64.6% below its 52-week high.

On profitability, Q32 Bio Inc. generates a return on equity (ROE) of 76.88% — well above the market average, a sign of a high-quality business, return on capital employed of 19.43%, an operating margin of 31.48%, a net profit margin of 62.87%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides